222530-39-4 Usage
Description
CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)is a complex organic chemical compound characterized by a cyclohexane ring, a carboxylic acid functional group, and a 3-[(1,1-dimethylethoxy)carbonyl]amino moiety. Its stereochemistry is defined by the (1R,3S) configuration, which is crucial for its potential applications in various fields. CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)is primarily recognized for its role as a building block in organic synthesis and pharmaceutical research, with its unique structure and properties suggesting potential for the development of new drugs or materials.
Uses
Used in Organic Synthesis:
CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)is utilized as a key intermediate in organic synthesis for the creation of various complex organic molecules. Its unique structure allows for the formation of multiple chemical bonds and reactions, making it a valuable component in the synthesis of specialty chemicals and pharmaceuticals.
Used in Pharmaceutical Research:
In the pharmaceutical industry, CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)serves as a crucial building block for the development of new drugs. Its specific stereochemistry and functional groups can be leveraged to design molecules with targeted therapeutic effects, potentially leading to the discovery of novel treatments for various diseases.
Used in Drug Development:
CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)-'s potential applications in drug development are vast due to its unique structural features. CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)can be modified and optimized to create new drug candidates with improved pharmacological properties, such as enhanced efficacy, selectivity, and reduced side effects.
Used in Material Science:
Beyond its applications in organic synthesis and pharmaceuticals, CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)may also find use in the development of new materials. Its structural properties could be harnessed to create innovative materials with unique characteristics for use in various industries, such as coatings, adhesives, or polymers.
Check Digit Verification of cas no
The CAS Registry Mumber 222530-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,2,5,3 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 222530-39:
(8*2)+(7*2)+(6*2)+(5*5)+(4*3)+(3*0)+(2*3)+(1*9)=94
94 % 10 = 4
So 222530-39-4 is a valid CAS Registry Number.
222530-39-4Relevant articles and documents
Synthesis of cyclic γ-amino acids for foldamers and peptide nanotubes
Rodriguez-Vazquez, Nuria,Salzinger, Stephan,Silva, Luis F.,Amorin, Manuel,Granja, Juan R.
, p. 3477 - 3493 (2013/07/11)
Cyclic γ-amino acids are molecular building blocks of great interest in peptide and foldamer chemistry, as they allow the preparation of new structures that are not found in Nature. In this paper, we describe the synthesis of cyclic γ-amino acids that have a cis relationship between the amino and the carboxylic acid groups. This arrangement, in most cases, induces the resulting peptides to adopt a flat conformation, which makes them appropriate for the design of foldamers that adopt β-sheet-type structures. We describe the synthesis of cyclic γ-amino acids that have a cis relationship between the amino and the carboxylic acid groups. This makes them suitable for the design of foldamers that adopt β-sheet-type structures.
Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure
Yamazaki, Kazuo,Kaneko, Yasushi,Suwa, Kie,Ebara, Shinji,Nakazawa, Kyoko,Yasuno, Kazuhiro
, p. 2509 - 2522 (2007/10/03)
Two parallel synthetic methods using solid-supported reagents were established to examine the rapid optimization of weak hit compound 1. Several compounds showed high potency in the low nanomolar range against N-myristoyltransferase. The structure-activity relationship (SAR) and antifungal activities of a series of novel 2-aminobenzothiazole N-myristoyltransferase inhibitors are presented.
New cyclic peptide assemblies with hydrophobic cavities: The structural and thermodynamic basis of a new class of peptide nanotubes
Amorin, Manuel,Castedo, Luis,Granja, Juan R.
, p. 2844 - 2845 (2007/10/03)
A new class of self-assembling peptides based on cyclic peptides made of alternating 3-aminocyclohexanecarboxylic acid (γ-Acc) and α-amino acids is described. The studied cylindrical assemblies are models for a new class of self-assembling peptide nanotub
